Who are AstronauTX Ltd's investors?

AstronauTX Ltd's investors include Brandon Capital, Dementia Discovery Fund, MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.

AstronauTX Ltd

Founded 2019 · 26 employees on LinkedIn · 7 known investors

Find your way into AstronauTX Ltd

Paths you didn't know you had: your email and LinkedIn already hold routes to the AstronauTX Ltd team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.

Biotech Deep Tech Healthtech Longevity Medical Devices

Founders & leadership

Jane Rhodes Chief Executive OfficerJane Rhodes is a neuroscientist and CEO of AstronauTx, a biotechnology company developing drug candidates for neurodegenerative and neuroinflammatory diseases.

Magnus IvarssonChief Scientific OfficerChief Scientific Officer at 0 2 AstronauTx

Hannah PearceChief Operating OfficerChief Operating Officer at 0 2 AstronauTx

Michelle L. Mellion Chief Medical OfficerMichelle L. Mellion is a board-certified neurologist and clinical neurophysiologist with over 20 years of experience in clinical care, research, and drug development across biotech. She trained at Wake Forest University School of Medicine and Brown University, served as Neurology Residency Program Director and Clinical Neurophysiology Fellowship Director at Brown, and has led early- and late-phase clinical trial programs in CNS disorders including neurodegeneration and neuromuscular disease.

Investors · 7

Brandon Capitallisted by Brandon CapitalMelbournevia Jonathan Tobin · inferred

How we know: Brandon Capital's portfolio page · a partner's Signal profile · Not right? Tell us

Dementia Discovery Fundlisted by Dementia Discovery FundLondon

How we know: Dementia Discovery Fund's portfolio page · Not right? Tell us

MPM BioImpactlisted by MPM BioImpactBoston · $1M – $15M

How we know: MPM BioImpact's portfolio page · Not right? Tell us

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M

How we know: SV Health Investors's portfolio page · Not right? Tell us

UCL Technology Fundlisted by UCL Technology FundLondon · $320K – $9M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

AlbionVCreportedLondon

How we know: a partner's Signal profile · Not right? Tell us

Frequently asked questions

What does AstronauTX Ltd do?: AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.
Who are AstronauTX Ltd's investors?: AstronauTX Ltd's investors include Brandon Capital, Dementia Discovery Fund, MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.